Stelios F Assimakopoulos1, Christos Triantos2, Konstantinos Thomopoulos2, Fotini Fligou3, Ioannis Maroulis4, Markos Marangos5, Charalambos A Gogos5. 1. Department of Internal Medicine, Division of Infectious Diseases, University of Patras Medical School, 26504, Patras, Greece. sassim@upatras.gr. 2. Department of Internal Medicine, Division of Gastroenterology, University of Patras Medical School, 26504, Patras, Greece. 3. Department of Anesthesiology and Critical Care Medicine, University of Patras Medical School, 26504, Patras, Greece. 4. Department of Surgery, University of Patras Medical School, 26504, Patras, Greece. 5. Department of Internal Medicine, Division of Infectious Diseases, University of Patras Medical School, 26504, Patras, Greece.
Abstract
INTRODUCTION: Gut permeability is increased in critically ill patients, and associated with the development of the systemic inflammatory response syndrome and multiple organ dysfunction syndrome (MODS). The pathogenetic link(s) and potential therapies are an area of intense research over the last decades. METHODS: We thoroughly reviewed the literature on gut-origin sepsis and MODS in critically ill patients, with emphasis on the implicated pathophysiological mechanisms and therapeutic interventions. FINDINGS: Intestinal barrier failure leading to systemic bacterial translocation associated with MODS was the predominant pathophysiological theory for several years. However, clinical studies with critically ill patients failed to provide the evidence of systemic spread of gut-derived bacteria and/or their products as a cause of MODS. Newer experimental data highlight the role of the mesenteric lymph as a carrier of gut-derived danger-associated molecular patterns (DAMPs) to the lung and the systemic circulation. These substances are recognized by pattern recognition receptor-bearing cells in diverse tissues and promote proinflammatory pathways and the development MODS. Therefore, the gut becomes a pivotal proinflammatory organ, driving the systemic inflammatory response through DAMPs release in mesenteric lymph, without the need for systemic bacterial translocation. CONCLUSIONS: There is an emerging need for application of sensitive non-invasive and easily measured biomarkers of early intestinal injury (e.g., citrulline, intestinal fatty acid protein, and zonulin) in our everyday clinical practice, guiding the early pharmacological intervention in critically ill patients to restore or prevent intestinal injury and improve their outcomes.
INTRODUCTION: Gut permeability is increased in critically illpatients, and associated with the development of the systemic inflammatory response syndrome and multiple organ dysfunction syndrome (MODS). The pathogenetic link(s) and potential therapies are an area of intense research over the last decades. METHODS: We thoroughly reviewed the literature on gut-origin sepsis and MODS in critically illpatients, with emphasis on the implicated pathophysiological mechanisms and therapeutic interventions. FINDINGS: Intestinal barrier failure leading to systemic bacterial translocation associated with MODS was the predominant pathophysiological theory for several years. However, clinical studies with critically illpatients failed to provide the evidence of systemic spread of gut-derived bacteria and/or their products as a cause of MODS. Newer experimental data highlight the role of the mesenteric lymph as a carrier of gut-derived danger-associated molecular patterns (DAMPs) to the lung and the systemic circulation. These substances are recognized by pattern recognition receptor-bearing cells in diverse tissues and promote proinflammatory pathways and the development MODS. Therefore, the gut becomes a pivotal proinflammatory organ, driving the systemic inflammatory response through DAMPs release in mesenteric lymph, without the need for systemic bacterial translocation. CONCLUSIONS: There is an emerging need for application of sensitive non-invasive and easily measured biomarkers of early intestinal injury (e.g., citrulline, intestinal fatty acid protein, and zonulin) in our everyday clinical practice, guiding the early pharmacological intervention in critically illpatients to restore or prevent intestinal injury and improve their outcomes.
Authors: Marc Gh Besselink; Hjalmar C van Santvoort; Erik Buskens; Marja A Boermeester; Harry van Goor; Harro M Timmerman; Vincent B Nieuwenhuijs; Thomas L Bollen; Bert van Ramshorst; Ben Jm Witteman; Camiel Rosman; Rutger J Ploeg; Menno A Brink; Alexander Fm Schaapherder; Cornelis Hc Dejong; Peter J Wahab; Cees Jhm van Laarhoven; Erwin van der Harst; Casper Hj van Eijck; Miguel A Cuesta; Louis Ma Akkermans; Hein G Gooszen Journal: Lancet Date: 2008-02-14 Impact factor: 79.321
Authors: Elliot C Williams; Raul Coimbra; Theresa W Chan; Andrew Baird; Brian P Eliceiri; Todd W Costantini Journal: J Trauma Acute Care Surg Date: 2019-01 Impact factor: 3.313
Authors: Ali Shawki; Rocio Ramirez; Marianne R Spalinger; Paul M Ruegger; Anica Sayoc-Becerra; Alina N Santos; Pritha Chatterjee; Vinicius Canale; Jonathan D Mitchell; John C Macbeth; Casey M Gries; Michel L Tremblay; Ansel Hsiao; James Borneman; Declan F McCole Journal: Gut Microbes Date: 2020-06-26
Authors: Lan Xiao; Xiang-Xue Ma; Jason Luo; Hee K Chung; Min S Kwon; Ting-Xi Yu; Jaladanki N Rao; Rosemary Kozar; Myriam Gorospe; Jian-Ying Wang Journal: Gastroenterology Date: 2021-06-09 Impact factor: 33.883